Future perspectives: Moving towards NCL treatments.

about

Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infantile neuronal ceroid lipofuscinosis and other lipid storage disorders.Searching for novel biomarkers using a mouse model of CLN3-Batten disease

P2860

Q33808609-7B1E89EF-DD8F-4233-95BE-2AB350A93E79 Q58797972-0ECFC0B3-90A1-4043-B8CF-9A8AC7805466

P2860

Future perspectives: Moving towards NCL treatments.

Item

http://www.wikidata.org/entity/Q38413183

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Future perspectives: Moving towards NCL treatments.

@en

type

Item

label

Future perspectives: Moving towards NCL treatments.

@en

prefLabel

Future perspectives: Moving towards NCL treatments.

@en

P1476

Future perspectives: Moving towards NCL treatments.

@en

P2093

Romina Kohan

http://www.w3.org/2001/XMLSchema#string

Susan L Cotman

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis

Metabolomics of human brain aging and age-related neurodegenerative diseases

Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium

Generation of cerebral organoids from human pluripotent stem cells

A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system.

Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA.

Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease).

Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis

Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage.

Standardized assessment of seizures in patients with juvenile neuronal ceroid lipofuscinosis

P304

2336-2338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBADIS.2015.04.001

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

10 Pt B

http://www.w3.org/2001/XMLSchema#string

P478

1852

http://www.w3.org/2001/XMLSchema#string

P50

Sara E. Mole

P577

2015-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274724012

http://www.w3.org/2001/XMLSchema#string

P698

25857620

http://www.w3.org/2001/XMLSchema#string

P932

4567439

http://www.w3.org/2001/XMLSchema#string

Future perspectives: Moving towards NCL treatments.

about

P2860

P2860

Future perspectives: Moving towards NCL treatments.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932